Reply Hypochloremia in Acute Decompensated Heart Failure by Grodin, Justin L. et al.
J A C C V O L . 6 6 , N O . 2 3 , 2 0 1 5 Letters
D E C E M B E R 1 5 , 2 0 1 5 : 2 6 7 8 – 8 5
2683with acute decompensated heart failure (ADHF). The
prognostic value of chloride level may reﬂect greater
congestion (dilution), diuresis (depletion), or acid-
base disturbance (buffer) and deserves discussion in
the context of the data presented by the authors.
Free water excess often produces hyponatremia in
ADHF (2) and would similarly result in dilutional
hypochloremia. A greater absolute reduction in so-
dium compared with chloride level would be ex-
pected at a particular degree of dilution given the
higher sodium compared with chloride levels in the
extracellular ﬂuid. The data presented paradoxically
showed a greater reduction in chloride compared
with sodium, assuming normal sodium and chloride
levels of 140 mEq/l and 106 mEq/l (3), suggesting that
the degree of hypochloremia is unlikely to be dilution
alone. It is also unlikely that dilutional hypochlor-
emia would be prognostically more signiﬁcant than
dilutional hyponatremia.
Loop diuretics inhibit the sodium-potassium-
chloride cotransporter (stoichiometric balance of
1:1:2) and will produce a proportionately greater
reduction in chloride than sodium. In addition, chlo-
ride is readily altered to regulate plasma strong ion
difference (SID) and maintain the acid-base balance.
Chloride and sodium are the major strong anion and
cation in extracellular ﬂuid and key determinants of
SID. The electrochemical effects of SID affect water
dissociation and hence hydrogen ([Hþ]) concentra-
tion. As SID becomes more positive, [Hþ], a “weak”
cation decreases to maintain electrical neutrality. A
reduction in SID from a net increase in anions has the
opposite effect, resulting in acidosis. Hence, the larger
reduction in chloride relative to sodium may reﬂect
greater loop diuretic use and/or the presence of un-
measured anions, both of which may explain the
prognostic value of chloride levels. Additional data on
diuretic therapy and measures of acid-base balance
will shed light on these possible mechanisms.*Hoong Sern Lim, MD
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2246–51.REPLY: Hypochloremia in Acute
Decompensated Heart FailureWe appreciate the comments from Dr. Lim regarding
our analysis investigating the prognostic role of
serum chloride levels in acute decompensated heart
failure (ADHF). As discussed, chloride levels can
be affected by a diversity of mechanisms in ADHF.
Indeed, hypochloremia and hyponatremia can de-
velop by maladaptive neurohormonal responses in
ADHF that limit free water excretion. However, we
posit that association of hypochloremia and mortality
is likely a result of a chloride’s broader homeostatic
role in heart failure than sodium and even acid-base
status. As shown in the baseline characteristics of
our analysis, chloride levels were positively cor-
related with sodium levels and negatively correlated
with serum bicarbonate levels (1). These ﬁndings
highlight 2 of chloride’s roles: 1) that of an extracel-
lular solute complementary to sodium; and 2) that
of an acid buffer to cations. Because both factors can
confound the risk relationship of chloride with mor-
tality, they were a priori included in the multivariable
model. Neither was signiﬁcantly associated with
mortality after adjustment for chloride levels, thus
implying that that it is actually the chloride levels
that play the larger prognostic role.
An approximation of the strong ion difference (SID)
can be estimated as the difference between sodium
and chloride concentrations (2). Indeed, the SID was
also associated with mortality in our cohort (hazard
ratio [HR]: 1.07; 95% conﬁdence interval [CI]: 1.04 to
1.10; p < 0.001). However, although the SID remains
signiﬁcant when adjusting for sodium (HR: 1.08;
95% CI: 1.05 to 1.10; p < 0.001), the association dis-
appeared when adjusting for chloride (HR: 1.01;
95% CI: 0.98 to 1.05; p ¼ 0.39), whereas the association
of chloride and mortality remains signiﬁcant. Never-
theless, we caution the incorporation of sodium and
chloride levels within the same statistical model as
the SID due to collinearity. Taken together, although
the framework of interpreting the SID is mechanisti-
cally insightful, chloride levels are simpler to inter-
pret and seem to be the main prognostic role player.
Diuretic therapy plays an important pathophysio-
logical role in the generation of hypochloremia in
heart failure, especially because it may be a more
Letters J A C C V O L . 6 6 , N O . 2 3 , 2 0 1 5
D E C E M B E R 1 5 , 2 0 1 5 : 2 6 7 8 – 8 5
2684sensitive marker of a depletional state (2). Although
inclusion in our cohort required loop diuretic use,
there were limited granular data on diuretic dosing
during hospitalization in our dataset. Therefore, we
were unable to draw any speciﬁc mechanistic con-
clusions regarding the contribution of diuretics to the
generation of hypochloremia.Justin L. Grodin, MD
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Is There an Ultimate Winner?We thank Drs. Agarwal and Argulian for their interest
in our review of coronary computed tomography
angiography (CCTA) for chest pain evaluation,
particularly in the context of serving as a “gate-
keeper” to unnecessary invasive coronary angiog-
raphy (ICA) (1,2). Based on the results of the recently
published PROMISE trial, which evaluated anatomic
versus functional imaging in a low- to intermediate-
risk cohort with suspected coronary artery disease
(CAD), Drs. Agarwal and Argulian assert stress echo-
cardiography as a “winner” in testing strategies
for the evaluation of patients with suspected CAD
(3). These claims, as argued by the letter writers,
are substantiated by the absence of ionizing radia-
tion, efﬁciency, and generally low cost of stress
echocardiography.
Although well intentioned, these assertions over-
simplify a complex interplay of an array of important
factors to consider, including the indication and
intent of testing, the patient population being tested,
the diagnostic performance of a test for any CAD andactionable CAD, the prognostic utility of imaging test
ﬁndings, and the inﬂuence of a diagnostic test ﬁnding
to encourage therapy in a fashion that improves
event-free survival. In our paper, we examined the
evidence supporting the use of CCTA as a “gate-
keeper” to unnecessary ICA in a patient population
that differs greatly from that enrolled in the PROMISE
trial, the study that Drs. Agarwal and Argulian cite.
Instead, we discussed the “anatomic-physiologic”
discordance that has been often observed for con-
ventional stress imaging wherein apparent ischemia
is present in the absence of high-grade anatomic CAD
at follow-up ICA. These ﬁndings do not necessarily
reﬂect a failure of stress imaging modalities to iden-
tify important cardiovascular ﬁndings but can repre-
sent alternative nonepicardial CAD processes that can
be elicited by stress imaging tests that inﬂuence
symptoms, diagnosis, and prognosis—a point fully
discussed in our paper.
Germane to this point, we also discussed the recent
iterations in CCTA wherein fractional ﬂow reserve
(FFRCT) can be noninvasively calculated at any point
in the coronary vascular bed from typically acquired
CCTA. This technology now allows for determination
of lesion-speciﬁc ischemia, a test ﬁnding eluded
by previous-generation imaging technologies. This
method for CAD evaluation is in its early stage
of clinical development, and we discussed the
emerging multicenter trials that will further evaluate
its efﬁcacy.
Finally, we highlighted the multitude of addi-
tional factors needed for consideration when evalu-
ating a patient with suspected CAD being considered
for ICA. Patient characteristics, test proﬁles, reason
for testing, clinical settings, test availability, local
expertise, payer coverage, functional capacity,
comorbidities, and a host of other important clinic-
economic considerations require consideration
before declaring any one imaging method an “ulti-
mate winner.” Drs. Agarwal and Argulian state that
the available literature favors stress echocardiogra-
phy as the winner thus far, but this assertion is un-
substantiated by scientiﬁc evidence. Indeed, the
totality of large-scale prospective multicenter studies
to date argues in favor of no single imaging modality
but rather has served to educate physicians as
to the beneﬁts and limitations of each testing
method, has emphasized that a binary dichotomy of
“this test versus that test” as an all-or-nothing
strategy is inappropriate, and has emphasized a
nuanced approach to judicious use of cardiac
imaging as the clinical standard, as reﬂected by
the contemporary American College of Cardiology/
